Siegfried Holding AG (SFZN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Siegfried Holding AG (SFZN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9924
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding intermediates and controlled substances. Siegfried also offers development and production services for finished dosage forms including sterile filling. It serves principally companies operating in pharmaceutical industry. It has production facilities in the USA, Switzerland, Malta, China, Germany and France. The company offers its products in USA Europe and other countries. Siegfried is headquartered in Zofingen, Aargau Switzerland.

Siegfried Holding AG (SFZN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Siegfried Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Siegfried to Acquire Zofingen Manufacturing Facility from Arena Pharma 10
Siegfried Acquires API Businesses from BASF 11
Debt Offering 12
Siegfried to Raise Additional USD15.4 Million in Public Offering of 2.125% Bond Due 2021 12
Siegfried Raises USD149.6 Million in Public Offering of 2.125 Bond Due 2021 13
Siegfried Holding Raises USD61.33 Million in Bonds Offering 14
Acquisition 15
Siegfried Acquires Hameln Pharma for USD62 Million 15
Siegfried Acquires Alliance Medical Products For US$58 Million 16
Siegfried Holding AG – Key Competitors 17
Siegfried Holding AG – Key Employees 18
Siegfried Holding AG – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
Aug 21, 2018: Siegfried reports higher sales and further improved margin for first half year 21
Mar 14, 2018: Siegfried with Sales and Margin Growth 23
Aug 23, 2017: Siegfried Reports Higher Profit and Increased Margin for First Six Months 24
Mar 14, 2017: Siegfried with Jump in Sales in 2016 25
Corporate Communications 26
Jun 04, 2018: Siegfried Group: Change in the Executive Committee 26
Mar 21, 2017: Siegfried Group: Management Changes 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Siegfried Holding AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Siegfried Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Siegfried Holding AG, Deals By Therapy Area, 2012 to YTD 2018 8
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Siegfried to Acquire Zofingen Manufacturing Facility from Arena Pharma 10
Siegfried Acquires API Businesses from BASF 11
Siegfried to Raise Additional USD15.4 Million in Public Offering of 2.125% Bond Due 2021 12
Siegfried Raises USD149.6 Million in Public Offering of 2.125 Bond Due 2021 13
Siegfried Holding Raises USD61.33 Million in Bonds Offering 14
Siegfried Acquires Hameln Pharma for USD62 Million 15
Siegfried Acquires Alliance Medical Products For US$58 Million 16
Siegfried Holding AG, Key Competitors 17
Siegfried Holding AG, Key Employees 18
Siegfried Holding AG, Subsidiaries 19

List of Figures
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Siegfried Holding AG (SFZN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Amicus Therapeutics Inc (FOLD):製薬・医療:M&Aディール及び事業提携情報
    Summary Amicus Therapeutics Inc (Amicus Therapeutics) is a biotechnology company that focuses on the research, development and commercialization of small molecules drugs and orally administered drugs known as pharmacological chaperones for the treatment of rare and orphan diseases. The company's lea …
  • Natcore Technology Inc (NXT):企業の財務・戦略的SWOT分析
    Summary Natcore Technology Inc (Natcore) is a solar research and development company that provides products for semiconductor and fiber optic applications. The company’s products include solar cell structures and black silicon cells. It uses liquid phase deposition technology for controlling deposit …
  • Terme Catez D.D.
    Terme Catez D.D. - Strategy, SWOT and Corporate Finance Report Summary Terme Catez D.D. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kepler Weber SA (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber SA (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Desitin Arzneimittel GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Desitin Arzneimittel GmbH (Desitin) formerly Desitin Compagnie mbH, is a specialty pharmaceutical company which develops and produces products for the treatment of central nervous system (CNS) related neurological and psychiatric diseases. Its product portfolio includes antiepileptic drugs a …
  • Aster DM Healthcare-製薬・医療分野:企業M&A・提携分析
    Summary Aster DM Healthcare (Aster DM), formerly Dr Moopens Healthcare Management Services LLC is a healthcare service provider that provides patient care services. The company offers services such as cardiac surgery, mobile medical units, village adoption, early cancer detection centers and dialysi …
  • RTL Group S.A. (RTL):企業の財務・戦略的SWOT分析
    RTL Group S.A. (RTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Compagnie Generale des Etablissements Michelin:企業の戦略・SWOT・財務分析
    Compagnie Generale des Etablissements Michelin - Strategy, SWOT and Corporate Finance Report Summary Compagnie Generale des Etablissements Michelin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • MRF Ltd (MRF):企業の財務・戦略的SWOT分析
    MRF Ltd (MRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • BMO Private Bank:企業の戦略・SWOT・財務情報
    BMO Private Bank - Strategy, SWOT and Corporate Finance Report Summary BMO Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Atomenergoprom:企業の戦略的SWOT分析
    Atomenergoprom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • BNC Bancorp:企業のM&A・事業提携・投資動向
    BNC Bancorp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BNC Bancorp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Weifang Changan Steel Tower Stock Co Ltd:企業の戦略的SWOT分析
    Weifang Changan Steel Tower Stock Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Cielo Wind Power, LP-エネルギー分野:企業M&A・提携分析
    Summary Cielo Wind Power, LP (Cielo Wind) is a wind power project development company. It designs, develops, owns and operates utility-grade wind power projects. The company provides a wide range of services including engineering, construction, operations and maintenance, land procurement, meteorolo …
  • Taiwan Cogeneration Corp (8926):企業の財務・戦略的SWOT分析
    Summary Taiwan Cogeneration Corp (Taiwan Cogeneration) is a power company that offers power and electrical energy generation and cogeneration services. The corporation provides services such as construction, investment, operation, and management of power and energy generation cogeneration plants in …
  • EOH Holdings Ltd (EOH):企業の財務・戦略的SWOT分析
    EOH Holdings Ltd (EOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CD Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary CD Diagnostics Inc (CD Diagnostics), a subsidiary of Zimmer Biomet Holdings Inc is an integrated diagnostics company that develops immunoassays that improve patient outcomes. The company provides synovascure analytical tools. Its products are used in alpha defenses, CRP, hemoglobin tests, in …
  • Liberty House Group:企業の戦略・SWOT・財務情報
    Liberty House Group - Strategy, SWOT and Corporate Finance Report Summary Liberty House Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Orascom Development Egypt Sae:企業の戦略・SWOT・財務分析
    Orascom Development Egypt Sae - Strategy, SWOT and Corporate Finance Report Summary Orascom Development Egypt Sae - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Syntimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Syntimmune Inc (Syntimmune) is a clinical-stage biotechnology company that focuses to develop Fc receptor (FcRn) based antibody therapeutics for the treatment of autoimmune diseases. Its lead pipeline products includes SYNT001, an investigational humanized IgG4 monoclonal antibody that inhib …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆